USFDA concludes inspection at Zydus Cadila’s API manufacturing facilities in Ankleshwar

27 Jul 2019

US Food and Drug Administration (USFDA) has inspected the Zydus Cadila’s API manufacturing facility located at Ankleshwar in Gujarat. The inspection was conducted from July 22, 2019 to July 26, 2019. This audit covered both Unit I and II. At the end of the inspection, no observation (483) is issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

488.55 -11.40 (-2.28%) Apr 13, 18:01
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 627.40
Dr. Reddys Lab 4780.60
Lupin 1037.15
Piramal Enterprises 1715.00
Cadila Healthcare 488.55
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323